Amylyx Pharmaceuticals
AMLX
AMLX
109 hedge funds and large institutions have $141M invested in Amylyx Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 36 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
74% less call options, than puts
Call options by funds: $796K | Put options by funds: $3.04M
Holders
109
Holding in Top 10
–
Calls
$796K
Puts
$3.04M
Top Buyers
| 1 | +$15M | |
| 2 | +$6.89M | |
| 3 | +$6.01M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.55M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$2.17M |
Top Sellers
| 1 | -$8.72M | |
| 2 | -$3.68M | |
| 3 | -$3.49M | |
| 4 |
Goldman Sachs
New York
|
-$3.23M |
| 5 |
Two Sigma Investments
New York
|
-$3.02M |